Reply to Adam G. Sowalsky, Stephen R. Plymate, Michael C. Haffner, Johann S. de Bono, and Adam Sharp's Letter to the Editor re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86: AR-V7 is Rare in Hormone-sensitive Prostate Cancer
第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept Urol,Tongji Med Coll,Wuhan,Peoples R China[2]Inst Urol Hubei Prov, Wuhan, Peoples R China
通讯作者：
通讯机构：[4]Canc Precis Diag & Treatment & Translat Med Hubei, Wuhan, Peoples R China[5]Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan, Peoples R China[*1]Wuhan Univ, Dept Urol, Zhongnan Hosp, 169 Donghu Rd, Wuhan 430071, Peoples R China
推荐引用方式(GB/T 7714)：
Li Heng,Zhang Yucong,Xu Hua.Reply to Adam G. Sowalsky, Stephen R. Plymate, Michael C. Haffner, Johann S. de Bono, and Adam Sharp's Letter to the Editor re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86: AR-V7 is Rare in Hormone-sensitive Prostate Cancer[J].EUROPEAN UROLOGY.2022,82(5):E137-E138.doi:10.1016/j.eururo.2022.08.013.
APA：
Li, Heng,Zhang, Yucong&Xu, Hua.(2022).Reply to Adam G. Sowalsky, Stephen R. Plymate, Michael C. Haffner, Johann S. de Bono, and Adam Sharp's Letter to the Editor re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86: AR-V7 is Rare in Hormone-sensitive Prostate Cancer.EUROPEAN UROLOGY,82,(5)
MLA：
Li, Heng,et al."Reply to Adam G. Sowalsky, Stephen R. Plymate, Michael C. Haffner, Johann S. de Bono, and Adam Sharp's Letter to the Editor re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86: AR-V7 is Rare in Hormone-sensitive Prostate Cancer".EUROPEAN UROLOGY 82..5(2022):E137-E138
医学